Fundraising Fox

64x

8 known investors

Find your way into 64x

64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics. The company uses massively parallelized screening and computational insights to engineer high-yield cell lines and production technologies that accelerate the manufacturing of next-generation medicines.

BiotechDeep TechMedical Devices

Investors · 8

BoxGroupNew York · $1M
Fifty YearsreportedSan Francisco · $250K – $2M
First Round CapitalreportedSan Francisco · $1M – $7M
Future VenturesreportedLos Altos · $1M – $10M
Lifeforce CapitalreportedChevy Chase · $500K – $5M
Northpond VenturesreportedBethesda · $100K – $5M
Refactor CapitalreportedBurlingame · $1M – $2M
SV AngelreportedSan Francisco

In the news

Biotech founders are turning to new VCs to raise their seed funding rounds. These are the top 19 investment firms you need to know for early-stage investing.businessinsider.com · Mar 202264x Bio bags $55m to drive cell production tech - BioProcess Insiderbioprocessintl.com · Jan 2022Harvard offshoot 64x Bio nets $55M in series A funding to expand cell production tech | Fierce Pharmafiercepharma.com · Jan 2022Pitch Deck: 64x Bio Raises $55 Million for Cell, Gene Therapy Tools. - Business Insiderbusinessinsider.com · Jan 202264x Bio Raises $55M in Series A Financingfinsmes.com · Jan 202264x Bio Raises $55 Million Series A Financing to Advance Cell Line Engineering Platform for Gene Therapy Manufacturingbusinesswire.com · Jan 2022

Frequently asked questions

What does 64x do?
64x provides a platform and product suite for manufacturing advanced therapeutics, including gene therapies, cell therapies, and biologics. The company uses massively parallelized screening and computational insights to engineer high-yield cell lines and production technologies that accelerate the manufacturing of next-generation medicines.
Who are 64x's investors?
64x's investors include BoxGroup, Fifty Years, First Round Capital, Future Ventures, Lifeforce Capital, Northpond Ventures, Refactor Capital, SV Angel.